Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 361 to 363 of 363 entries
Sorted by: Best Match Show Resources per page
Antithrombotic / Antiplatelet Therapy in Patients with Stable Coronary Artery Disease and After Acute Coronary Syndrome.

Cardiovascular & hematological agents in medicinal chemistry

Cruz Rodriguez JB, Mishra K, Siddiqui T.
PMID: 33290202
Cardiovasc Hematol Agents Med Chem. 2021;19(2):187-200. doi: 10.2174/1871525718666201207201552.

The major physiopathological mechanism underlying Acute Coronary Syndromes (ACS) is atherosclerotic plaque rupture with resultant coronary thrombosis, posing a big burden in health care systems. Dual anti-platelet therapy (DAPT) can improve CV outcome with a prolonged regimen, albeit at...

Cite
Cruz Rodriguez JB, Mishra K, Siddiqui T. Antithrombotic / Antiplatelet Therapy in Patients with Stable Coronary Artery Disease and After Acute Coronary Syndrome. Cardiovasc Hematol Agents Med Chem. 2021;19(2):187-200doi: 10.2174/1871525718666201207201552.
Cruz Rodriguez, J. B., Mishra, K., & Siddiqui, T. (2021). Antithrombotic / Antiplatelet Therapy in Patients with Stable Coronary Artery Disease and After Acute Coronary Syndrome. Cardiovascular & hematological agents in medicinal chemistry, 19(2), 187-200. https://doi.org/10.2174/1871525718666201207201552
Cruz Rodriguez, Jose B, et al. "Antithrombotic / Antiplatelet Therapy in Patients with Stable Coronary Artery Disease and After Acute Coronary Syndrome." Cardiovascular & hematological agents in medicinal chemistry vol. 19,2 (2021): 187-200. doi: https://doi.org/10.2174/1871525718666201207201552
Cruz Rodriguez JB, Mishra K, Siddiqui T. Antithrombotic / Antiplatelet Therapy in Patients with Stable Coronary Artery Disease and After Acute Coronary Syndrome. Cardiovasc Hematol Agents Med Chem. 2021;19(2):187-200. doi: 10.2174/1871525718666201207201552. PMID: 33290202.
Copy Download .nbib Format: NLM
Prevalence of the E321G MYH1 variant in Brazilian Quarter Horses.

Equine veterinary journal

de Albuquerque AL, Zanzarini Delfiol DJ, Andrade DGA, Albertino LG, Sonne L, Borges AS, Valberg SJ, Finno CJ, Oliveira-Filho JP.
PMID: 34606642
Equine Vet J. 2021 Oct 04; doi: 10.1111/evj.13521. Epub 2021 Oct 04.

BACKGROUND: In the Quarter Horse (QH), myosin heavy chain myopathy (MYHM), which is characterised by nonexertional rhabdomyolysis or immune-mediated myositis (IMM) with acute muscle atrophy, is strongly associated with the missense E321G MYH1 mutation.OBJECTIVES: To document the existence of...

Cite
de Albuquerque AL, Zanzarini Delfiol DJ, Andrade DGA, et al. Prevalence of the E321G MYH1 variant in Brazilian Quarter Horses. Equine Vet J. 2021;doi: 10.1111/evj.13521.
de Albuquerque, A. L., Zanzarini Delfiol, D. J., Andrade, D. G. A., Albertino, L. G., Sonne, L., Borges, A. S., Valberg, S. J., Finno, C. J., & Oliveira-Filho, J. P. (2021). Prevalence of the E321G MYH1 variant in Brazilian Quarter Horses. Equine veterinary journal, . https://doi.org/10.1111/evj.13521
de Albuquerque, Ana L, et al. "Prevalence of the E321G MYH1 variant in Brazilian Quarter Horses." Equine veterinary journal vol. (2021). doi: https://doi.org/10.1111/evj.13521
de Albuquerque AL, Zanzarini Delfiol DJ, Andrade DGA, Albertino LG, Sonne L, Borges AS, Valberg SJ, Finno CJ, Oliveira-Filho JP. Prevalence of the E321G MYH1 variant in Brazilian Quarter Horses. Equine Vet J. 2021 Oct 04; doi: 10.1111/evj.13521. Epub 2021 Oct 04. PMID: 34606642.
Copy Download .nbib Format: NLM
Patient, caregiver, and health care provider perspectives on barriers and facilitators to heart failure care in Kerala, India: A qualitative study.

Wellcome open research

Jose P, Ravindranath R, Joseph LM, Rhodes EC, Ganapathi S, Harikrishnan S, Jeemon P.
PMID: 33959683
Wellcome Open Res. 2021 Apr 19;5:250. doi: 10.12688/wellcomeopenres.16365.2. eCollection 2020.

No abstract available.

Cite
Jose P, Ravindranath R, Joseph LM, et al. Patient, caregiver, and health care provider perspectives on barriers and facilitators to heart failure care in Kerala, India: A qualitative study. Wellcome Open Res. 2021;5:250doi: 10.12688/wellcomeopenres.16365.2.
Jose, P., Ravindranath, R., Joseph, L. M., Rhodes, E. C., Ganapathi, S., Harikrishnan, S., & Jeemon, P. (2020). Patient, caregiver, and health care provider perspectives on barriers and facilitators to heart failure care in Kerala, India: A qualitative study. Wellcome open research, 5250. https://doi.org/10.12688/wellcomeopenres.16365.2
Jose, Prinu, et al. "Patient, caregiver, and health care provider perspectives on barriers and facilitators to heart failure care in Kerala, India: A qualitative study." Wellcome open research vol. 5 (2020): 250. doi: https://doi.org/10.12688/wellcomeopenres.16365.2
Jose P, Ravindranath R, Joseph LM, Rhodes EC, Ganapathi S, Harikrishnan S, Jeemon P. Patient, caregiver, and health care provider perspectives on barriers and facilitators to heart failure care in Kerala, India: A qualitative study. Wellcome Open Res. 2021 Apr 19;5:250. doi: 10.12688/wellcomeopenres.16365.2. eCollection 2020. PMID: 33959683; PMCID: PMC8078213.
Copy Download .nbib Format: NLM
Showing 361 to 363 of 363 entries